2022 NAAG Legislative Victories

As the chief legal officer of their state, attorneys general often provide important input on both regulatory and legislative proposals. This input is often provided through the National Association of Attorneys General (NAAG). As a nonpartisan organization, NAAG engages in policy advocacy only when an issue has bipartisan support from a majority of attorneys general….

Read More →

NAAG Urges DEA and SAMSHA to Extend Telehealth Capabilities for Opioid Use Disorder Treatment

A bipartisan group of 45 state attorneys general urge the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) to permanently extend telehealth flexibilities after the expiration of the public health emergency for prescribing buprenorphine, one of three Food and Drug Administration (FDA) approved medications for treating opioid use disorder. Buprenorphine…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: July 2022 Update for the Attorney General Community

On July 13, the U.S. reached over 222.6 million persons (67.1% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Nearly 400,000 children under five years of age have…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: June 2022 Update for the Attorney General Community

On June 17, the U.S. reached nearly 221.9 million persons (66.8% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Over 104.7 million persons in the U.S. have received…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: May 2022 Update for the Attorney General Community

On May 16, the U.S. reached nearly 220.6 million persons (66.4% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Over 102 million persons in the U.S. have received…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: March 2022 Update for the Attorney General Community

On March 24, the U.S. reached 255.1 million persons (76.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 217.3 million persons (65.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: February 2022 Update for the Attorney General Community

On February 18, the U.S. reached 252.5 million persons (76.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 214.5 million persons (64.6% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Crisis Standards of Care During the COVID-19 Pandemic: Legal and Policy-Related Issues

As various regions of the the United States experienced COVID-19-related surges in cases, hospitals and other providers have reported scarcity in essential resources (e.g., available intensive care unit (ICU) beds, personnel, treatments, and personal protective equipment (PPE)). In response, providers as well as state, territorial, and local health authorities have prepared and/or implemented crisis standards…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: January 2022 Update for the Attorney General Community

On January 18, the U.S. reached 249.4 million persons (75.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 209.3 million persons (63.0% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

NAAG Responds to FDA’s Comment Request on New Over-The-Counter Hearing Aid Rules

In response to a request for comments from the Food and Drug Administration (FDA) regarding new rules regulating over-the-counter hearing aids, NAAG submitted comments encouraging the FDA to take the below steps to ensure that states maintain a role as regulators in this emerging market: The FDA should define preemption terms in a way that…

Read More →